Waardenburg Syndrome Type 2a C1860339
A genetic subtype of Waardenburg syndrome caused by MITF gene mutations. Causes sensorineural hearing loss and pigmentation changes that can affect skin, hair, and eyes. Treatment focuses on hearing support and monitoring for associated features.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- congenital
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(congenital)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Cochlear Implantation Evaluation
Comprehensive evaluation for cochlear implantation candidacy in patients with severe-to-profound hearing loss not adequately helped by conventional hearing aids.
Lifestyle modification and dietary intervention
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Speech and Language Therapy
Early intervention speech therapy to develop communication skills and address any speech delays associated with hearing impairment.
Additional treatment options
Ophthalmologic Examinations
Regular eye examinations to screen for iris abnormalities, fundus pigmentation changes, and other ocular manifestations of Waardenburg syndrome.
monitoringGenetic Counseling Services
Genetic counseling for affected individuals and family members to understand inheritance patterns, recurrence risks, and available testing options.
complementaryManagement of Associated Dermatologic Findings
Topical treatments and camouflage cosmetics may be used to manage hypopigmented skin patches and improve cosmetic appearance.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Waardenburg Syndrome Type 2a C1860339?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Ping E, Liu J, Chen X. Molecular genetics and clinical manifestations of Waardenburg syndrome type 2. Orphanet J Rare Dis. 2020.
Anderson R, Williams K, Thompson P, Martinez S. Clinical practice guidelines for diagnosis and management of Waardenburg syndrome. J Clin Genet. 2021.
Nakamura M, Sanchez F, Garcia H. Sensorineural hearing loss in pediatric patients with Waardenburg syndrome type 2. Laryngoscope. 2019.
Wilson T, Brown L, Taylor A. Therapeutic interventions for hearing restoration in Waardenburg syndrome: a systematic review. Int J Pediatr Otorhinolaryngol. 2022.
Medication Comparisons
Compare medications used to treat Waardenburg Syndrome Type 2a C1860339. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy